Localized prostate cancer shows great clinical, genetic and environmental heterogeneity;
however, prostate cancer treatment is currently guided solely by clinical staging, serum PSA …

Urinary incontinence is a common and predictable consequence among men with localized
prostate cancer who have undergone radical prostatectomy. Despite advances in the …

Background Focal therapy (FT) and partial gland ablation (PGA) are quickly adopted by
urologists and radiologists as an option for the management of localized prostate cancer …

Prostate cancer (PC) represents the most diagnosed and the second most lethal cancer in
men worldwide. Its development and progression occur in concert with alterations in the …

Chimeric antigen receptor (CAR) T cell immunotherapy involves the genetic modification of
the patient's own T cells so that they specifically recognize and destroy tumour cells …

Introduction Focal therapy (FT) ablates areas of prostate cancer rather than treating the
whole gland. We compared oncological outcomes of FT to radical prostatectomy (RP) …

Abstract Introduction Primary prostate cancer (PCa) can be visualized on prostate-specific
membrane antigen positron emission tomography (PSMA-PET) with high accuracy …

Background Hepatocellular carcinoma (HCC) is the fourth leading cause of cancer-related
death worldwide. Due to the high prevalence of hepatitis B virus (HBV) infection in China …

Context The clinical effectiveness of focal therapy (FT) for localised prostate cancer (PCa)
remains controversial. Objective To analyse the evidence base for primary FT for localised …

Purpose With the advance of screening techniques, there is a growing number of low-risk or
intermediate-risk prostate cancer (PCa) cases, remaining a serious threat to men's health …